![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4375 | |
C07D 498/22 | |||
A61P 1/00 |
(11) | Number of the document | 2672970 |
(13) | Kind of document | T |
(96) | European patent application number | 12745372.8 |
Date of filing the European patent application | 2012-02-10 | |
(97) | Date of publication of the European application | 2013-12-18 |
(45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/024746 |
Date | 2012-02-10 |
(87) | Number | WO 2012/109605 |
Date | 2012-08-16 |
(30) | Number | Date | Country code |
201161556649 P | 2011-11-07 | US | |
201161530905 P | 2011-10-18 | US | |
201261583024 P | 2012-01-04 | US | |
201161441902 P | 2011-02-11 | US |
(72) |
PARENT, Stephan, US
McQUEEN, Lisa, US
ANDRES, Patricia, US
SCHIELDS, Paul, US
WU, Yiduo, US
DING, Fei, US
SMIT, Jared P., US
|
(73) |
Salix Pharmaceuticals, Ltd.,
8510 Colonnade Center Drive, Raleigh, NC 27615,
US
|
(54) | FORMS OF RIFAXIMIN AND USES THEREOF |
FORMS OF RIFAXIMIN AND USES THEREOF |